July 06, 2020
In early June, AstraZeneca approached rival drugmaker Gilead Sciences to discuss a potential merger. Though some doubt the feasibility of such a deal, this would be the biggest healthcare merger on record.
April 30, 2020
With budgets tightening and department priorities shifting, now is the time for companies to evaluate outside legal counsel.
April 15, 2020
As businesses feel the stress from COVID-19, some are considering bringing patent prosecution in-house in order to cut costs. With clients tightening their budgets, how can firms demonstrate the cost savings and ROI they bring to the table?
March 23, 2020
Biopharmaceutical companies AbbVie Inc. and Allergan recently announced that they signed a consent decree with the U.S. Federal Trade Commission that will commit the companies to sell some properties if they commence a planned merger.
March 09, 2020
Driven by market demand for efficiencies and cost savings, law firms and IP departments are looking to implement more legal technology into their workflow. But after all the work you put into choosing the right tool, how do you get attorneys and staff members to adopt?
February 06, 2020
Executives at T-Mobile may be weighing a potential merger with Comcast, the largest U.S. cable provider.
January 27, 2020
Each new year brings a time for reflection and goal setting. Legal teams have a chance to review successes from last year, consider areas of improvement, and create a game plan for the upcoming year. How can you improve your patent practice in 2020? What changes can you make that will have the greatest impact on your current business strategy? The answer can likely be found with AI-powered...
November 19, 2019
Fiat Chrysler and Peugeot owner PSA Group recently announced the terms of a $48 billion merger that would create the world's fourth-largest automaker. A primary reason for the merger is to share the cost of developing electric and autonomous vehicles.
August 15, 2019
Pfizer and Mylan, the maker of EpiPens, are merging. Pfizer will offload Upjohn, its portfolio of drugs that are no longer protected by patents, including Viagra, Lipitor and Celebrex, combining with rival Mylan to create a new company that will have a new, yet-to-be-announced name.
United Technologies, an American multinational conglomerate, recently agreed to combine its aerospace business with military contractor Raytheon, creating a new manufacturing giant in the aerospace and defense sectors. Under the new name of Raytheon Technologies, the merged company would have about $74 billion in expected sales for 2019.